ONCOLOGY GENERAL
Total Payments
$1.5M
Transactions
6
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $700,000 | 1 | 0 |
| 2018 | $331,892 | 3 | 0 |
| 2017 | $500,000 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.5M | 6 | 100.0% |
Top Doctors Receiving Payments for ONCOLOGY GENERAL
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $1.5M | 6 |
Ad
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $1.5M
Product Information
- Type Drug
- Total Payments $1.5M
- Total Doctors 0
- Transactions 6
About ONCOLOGY GENERAL
ONCOLOGY GENERAL is a drug associated with $1.5M in payments to 0 healthcare providers, recorded across 6 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2017 to 2019. In 2019, $700,000 was paid across 1 transactions to 0 doctors.
The most common payment nature for ONCOLOGY GENERAL is "Unspecified" ($1.5M, 100.0% of total).